OR WAIT null SECS
April 25, 2025
Video
Young shared with his real-world experiences with etranacogene dezaparvovec gene therapy.
April 18, 2025
Article
Anemia can moderate the association between both conditions, increasing the risk of atherosclerotic cardiovascular disease.
April 16, 2025
Investigators believe the connection may account for a substantial number of anemia cases in children.
April 13, 2025
Anemia correction reduced perioperative rates but showed no significant impact on postoperative outcomes, emphasizing the need for prehabilitation strategies.
April 11, 2025
Despite no direct correlation being identified, this research highlights a potential association between the two conditions.
April 09, 2025
Investigators examined the safety of the recalled sickle cell disease medication through retrospective analysis of an FDA database.
April 05, 2025
Investigators encourage further study of treatment and therapy methods for childhood IBD.
March 31, 2025
This FDA News Month in Review provides a round-up of regulatory decisions from March 2025.
Patient-reported outcome measures display positive trends after hematopoietic stem cell transplantation for patients with sickle cell disease.
Ragni discussed unique advantages fitusiran offers over other approved therapies for hemophilia A or B.